The odds of having TN and HER2-Overexpressing subtype versus HR+/HER2- doubles when the tumour is bigger than 5cm (T3+T4) compared to tumours 2cm or under (T0+T1) (OR = 2.27; CI95% = [1.19–4.33]). The gene discussed is ERBB2; the disease is neoplasm.